$2.44T
Total marketcap
$74.73B
Total volume
BTC 50.68%     ETH 14.88%
Dominance

Orphazyme A/S OZYMF Stock

0.09 USD {{ price }} 8999900.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
6.4K USD
LOW - HIGH [24H]
0.09 - 0.09 USD
VOLUME [24H]
3.25K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2471.19 USD

Orphazyme A/S Price Chart

Orphazyme A/S OZYMF Financial and Trading Overview

Orphazyme A/S stock price 0.09 USD
Previous Close 0.12 USD
Open 0.12 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.12 - 0.12 USD
52 Week Range 0.01 - 0.39 USD
Volume 100 USD
Avg. Volume 1 USD
Market Cap 9.1M USD
Beta (5Y Monthly) 0.342145
PE Ratio (TTM) N/A
EPS (TTM) -2471.19 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

OZYMF Valuation Measures

Enterprise Value -38155908 USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.10338984
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.361

Trading Information

Orphazyme A/S Stock Price History

Beta (5Y Monthly) 0.342145
52-Week Change -68.76%
S&P500 52-Week Change 20.43%
52 Week High 0.39 USD
52 Week Low 0.01 USD
50-Day Moving Average 0.12 USD
200-Day Moving Average 0.16 USD

OZYMF Share Statistics

Avg. Volume (3 month) 1 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 35.31M
Float 25.8M
Short Ratio N/A
% Held by Insiders 1.35%
% Held by Institutions 7.14%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.28%
Return on Equity (ttm) -150.22%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -28028000 USD
Net Income Avi to Common (ttm) -38312000 USD
Diluted EPS (ttm) -2.46
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 42.46M USD
Total Cash Per Share (mrq) 1.2 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 3.553
Book Value Per Share (mrq) 1.18

Cash Flow Statement

Operating Cash Flow (ttm) -117945000 USD
Levered Free Cash Flow (ttm) -64086624 USD

Profile of Orphazyme A/S

Country United States
State N/A
City Copenhagen
Address Ole Maaløes Vej 3
ZIP 2200
Phone 45 70 70 29 80
Website https://www.orphazyme.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 1

Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Q&A For Orphazyme A/S Stock

What is a current OZYMF stock price?

Orphazyme A/S OZYMF stock price today per share is 0.09 USD.

How to purchase Orphazyme A/S stock?

You can buy OZYMF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Orphazyme A/S?

The stock symbol or ticker of Orphazyme A/S is OZYMF.

Which industry does the Orphazyme A/S company belong to?

The Orphazyme A/S industry is Biotechnology.

How many shares does Orphazyme A/S have in circulation?

The max supply of Orphazyme A/S shares is 71.07K.

What is Orphazyme A/S Price to Earnings Ratio (PE Ratio)?

Orphazyme A/S PE Ratio is now.

What was Orphazyme A/S earnings per share over the trailing 12 months (TTM)?

Orphazyme A/S EPS is -2471.19 USD over the trailing 12 months.

Which sector does the Orphazyme A/S company belong to?

The Orphazyme A/S sector is Healthcare.